3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
92
Lung Neoplasms
32
NSCLC
7
Brain Neoplasms
7
Meningeal Carcinomatosis
4
Neoplasm Metastasis
3
Carcinoma, Squamous Cell
2
Bronchial Neoplasms
2
Adenocarcinoma of Lung
2
Small Cell Lung Carcinoma
1
Sexual Dysfunction, Physiological
1
Resectable Non-small Cell Lung Cancer
1
Rare Tumour
1
Prostatic Neoplasms
1
Progression Free Survival
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-small Cell Carcinoma
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
1
Non-Small Cell Lung Cancer With EGFR T790M Mutation
1
Non-Small Cell Lung Cancer With EGFR Mutation
1
Non Small Cell Lung Cancer Metastatic
1
Neurocognitive
1
Neoplastic Cells, Circulating
1
Neoplasm, Residual
1
Lung Cancer Metastatic
1
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
1
Glioblastoma
1
Eunuchism
1
Erectile Dysfunction
1
Interventions
pembrolizumab
1
osimertinib
1
binimetinib
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Non-small Cell Carcinoma
×
osimertinib
×
Clear all
NCT04695925
2025-10-15
TOP
Sun Yat-sen University
Phase 3
Active not recruiting
294 enrolled